Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $2.18 Million - $2.95 Million
8,080 New
8,080 $2.61 Million
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $473,448 - $640,588
1,317 New
1,317 $499,000
Q2 2022

Aug 09, 2022

BUY
$463.67 - $597.16 $232,762 - $299,774
502 Added 75.49%
1,167 $578,000
Q1 2022

May 09, 2022

BUY
$524.57 - $735.42 $348,839 - $489,054
665 New
665 $375,000
Q4 2021

Feb 10, 2022

SELL
$708.84 - $794.68 $248,094 - $278,138
-350 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$657.71 - $825.77 $295,969 - $371,596
-450 Reduced 56.25%
350 $261,000
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $461,312 - $519,232
800 New
800 $515,000
Q1 2020

Apr 29, 2020

SELL
$320.01 - $409.07 $399,692 - $510,928
-1,249 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$319.73 - $374.2 $399,342 - $467,375
1,249 New
1,249 $462,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.